Table 2. Clinical and demographic data and preoperative/postoperative FOSS scores.
No | Age | Sex | Comorbidity | Maximal neophyte level | Preop FOSS |
Postop FOSS | P-value |
---|---|---|---|---|---|---|---|
1 | 55 | M | LSS | C4/5 | 2 | 0 | |
2 | 68 | F | C3/4 | 2 | 0 | ||
3 | 61 | M | C4/5 | 2 | 0 | ||
4 | 56 | M | OPLL LSS | C5/6 | 3 | 1 | |
5 | 71 | M | LSS DM | C3/4 | 2 | 1 | |
6 | 57 | M | C3/4 | 4 | 0 | ||
7 | 67 | M | OPLL DM | C4/5 | 2 | 1 | |
8 | 73 | M | DM | C4/5 | 3 | 0 | |
9 | 59 | M | OPLL DM | C5/6 | 2 | 0 | |
10 | 78 | M | M | C6/7 | 3 | 0 | |
Average | 2.5 | 0.3 | < .001 |
DM, diabetes mellitus; FOSS, functional outcome swallowing scale; LSS, lumbar spinal stenosis; OPLL, ossification of the posterior longitudinal ligament